Phio Pharmaceuticals Corp (NASDAQ: PHIO) on Tuesday, plunged -6.36% from the previous trading day, before settling in for the closing price of $1.1. Within the past 52 weeks, PHIO’s price has moved between $0.97 and $9.79.
Healthcare Sector giant saw their annual sales surged by 66.30% over the last five years. The company achieved an average annual earnings per share of 82.76%. With a float of $9.78 million, this company’s outstanding shares have now reached $10.76 million.
The firm has a total of 5 workers. Let’s measure their productivity.
Phio Pharmaceuticals Corp (PHIO) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Phio Pharmaceuticals Corp is 9.17%, while institutional ownership is 1.77%. The most recent insider transaction that took place on Nov 21 ’25, was worth 5,700. In this transaction Chairman, Pres. & CEO of this company bought 5,000 shares at a rate of $1.14, taking the stock ownership to the 281,421 shares. Before that another transaction happened on Nov 18 ’25, when Company’s Chairman, Pres. & CEO bought 5,000 for $1.27, making the entire transaction worth $6,350. This insider now owns 276,421 shares in total.
Phio Pharmaceuticals Corp (PHIO) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 82.76% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 59.13% during the next five years compared to 66.30% growth over the previous five years of trading.
Phio Pharmaceuticals Corp (NASDAQ: PHIO) Trading Performance Indicators
Phio Pharmaceuticals Corp (PHIO) is currently performing well based on its current performance indicators. A quick ratio of 6.90 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.24, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.00 in one year’s time.
Technical Analysis of Phio Pharmaceuticals Corp (PHIO)
Analysing the last 5-days average volume posted by the [Phio Pharmaceuticals Corp, PHIO], we can find that recorded value of 0.51 million was lower than the volume posted last year of 3.39 million. As of the previous 9 days, the stock’s Stochastic %D was 24.31%.
During the past 100 days, Phio Pharmaceuticals Corp’s (PHIO) raw stochastic average was set at 0.94%, which indicates a significant decrease from 7.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0861 in the past 14 days, which was lower than the 0.1406 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5213, while its 200-day Moving Average is $1.9402. Now, the first resistance to watch is $1.0867. This is followed by the second major resistance level at $1.1433. The third major resistance level sits at $1.1867. If the price goes on to break the first support level at $0.9867, it is likely to go to the next support level at $0.9433. Should the price break the second support level, the third support level stands at $0.8867.
Phio Pharmaceuticals Corp (NASDAQ: PHIO) Key Stats
Market capitalization of the company is 11.09 million based on 10,764K outstanding shares. Right now, sales total 0 K and income totals -7,150 K. The company made 0 K in profit during its latest quarter, and -2,390 K in sales during its previous quarter.
